Latest Breaking News On - Contingent value rights agreement - Page 5 : comparemela.com

Pineapple Energy (PEGY) Sells Substantially All Assets of Legacy Subsidiaries JDL Technologies, Incorporated and Ecessa Corporation

Pineapple Energy (PEGY) Sells Substantially All Assets of Legacy Subsidiaries JDL Technologies, Incorporated and Ecessa Corporation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKyle udsethEric ingvaldsonHawaii energy connectionCommunications systems incExchange commissionPineapple energy incTechnologies incorporatedEcessa corporation to theipguysPineapple energyEcessa corporationOnenet globalChief executive officer kyle udsethCommunications systemsMerger agreementContingent value rights agreement

Pineapple Energy Reports Sale of Substantially All of the

MINNETONKA, Minn., July 07, 2023 (GLOBE NEWSWIRE) Pineapple Energy Inc. (NASDAQ: PEGY), a leading provider of sustainable solar energy and back-up.

United statesEric ingvaldsonKyle udsethCommunications systems incEcessa corporation to theipguysHawaii energy connectionTechnologies incorporatedPineapple energy incExchange commissionPineapple energyEcessa corporationOnenet globalChief executive officer kyle udsethCommunications systemsMerger agreementContingent value rights agreement

Form SC 13E3/A Satsuma Pharmaceuticals, Filed by: Satsuma Pharmaceuticals, Inc

Form SC 13E3/A Satsuma Pharmaceuticals, Filed by: Satsuma Pharmaceuticals, Inc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMenlo parkState of delawareJoshua dubofskyJohn kollinsA satsuma pharmaceuticalsExchange commissionCorporation law of the state delawareShin nippon biomedical laboratories ltdLatham watkinsSecurities exchangeMerger sub incSatsuma pharmaceuticals incSatsuma pharmaceuticalsWall streetStatement under section

Ocuphire Pharma : 10-Q Filing Q1 2023

Item 2. Management s Discussion and Analysis of Financial Condition and Results of. | May 15, 2023

United statesAmy rabournRichardj rodgersRichard rodgersJonestrading institutional servicesExchange commissionMarket programFamygen life sciences incAudit committeeSecurities exchangeCompany descriptionDrug administrationRexahn pharmaceuticals incA gp alliance global partnersViatris incBiosense global

Form SC 14D9/A ALBIREO PHARMA, INC Filed by: ALBIREO PHARMA, INC

Form SC 14D9/A ALBIREO PHARMA, INC Filed by: ALBIREO PHARMA, INC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesKrishna veeraraghavanRonaldhw cooperWharton garrisonAnemone acquisition corpAlbireo pharma incName of subject companyExchange commissionIpsen biopharmaceuticals incSecurities exchangeSecurities exchange actSubject companyPerson filing statementChief executiveTelephone number